Identification and Clinical Validation of High HSP60 Expression Predicts Poor Prognosis in Patients with Ovarian Cancer
Min Zheng,1,* Shaoxing Li,1,* Jie Deng,1 Chaolin Huang,1 Hua Zhang2 1Department of Gynecology and Obstetrics, Clinical Medical College and The First Affiliated Hospital of Chengdu Medical College, Chengdu, People’s Republic of China; 2Department of Rehabilitation Medicine, Clinical M...
Saved in:
| Main Authors: | Zheng M, Li S, Deng J, Huang C, Zhang H |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-01-01
|
| Series: | International Journal of General Medicine |
| Subjects: | |
| Online Access: | https://www.dovepress.com/identification-and-clinical-validation-of-high-hsp60-expression-predic-peer-reviewed-fulltext-article-IJGM |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of lymphadenectomy in advanced-stage ovarian cancer: a meta-analysis
by: Carlo Ronsini, et al.
Published: (2024-11-01) -
Pre-treatment nutrition-related indicators and the prognosis of patients with newly diagnosed epithelial ovarian cancer: an ambispective cohort study
by: Shirui Wang, et al.
Published: (2025-01-01) -
Metabolic Syndrome Is Associated With Poor Prognosis in Patients With Breast Cancer Receiving Neoadjuvant Therapy
by: Youzhao Ma, et al.
Published: (2024-12-01) -
Low expression of WWC1, a tumor suppressor gene, is associated with aggressive breast cancer and poor survival outcome
by: Zhanwei Wang, et al.
Published: (2019-07-01) -
High expression of BBOX1 in paracancerous tissue is associated with poor prognosis in hepatocellular carcinoma patients
by: Runqi Fang, et al.
Published: (2024-11-01)